US$ 24.03
glp-1 issues for Weight Loss and Diabetes Adverse Effects of GLP-1 Receptor
Description
The BMJ , 392 , e085304

doi: 10.1210/jc.2012-3855 62 SukumaranV.TsuchimochiH.SonobeT.ShiraiM.PearsonJ

Impact The introduction of generic semaglutide is expected to lead to significant price reductions for these widely used GLP-1 drugs, making them more accessible to a larger patient population suffering from obesity and type 2 diabetes

Among non-users, injection aversion remains a meaningful barrier to uptake

He had a chronic obstructive pulmonary disease and was prescribed with inhaled long-acting beta-adrenoceptor agonists and steroids daily